An Evaluation of the Impact of REMS on Spontaneous Reporting for Marketed Products

被引：0
|
作者：
Jain, Reema [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
431
引用
收藏
页码：S183 / S183
页数：1
相关论文
共 50 条
  • [31] Impact of the intensified reporting requirements on reporting of suspected side effects of new pharmacological products in Denmark
    Hallgreen, Christine E.
    Al-Bader, Reema
    Nazmi, Rahat
    Jimenez-Solem, Espen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 261 - 261
  • [32] Impact of COVID-19 vaccination on pharmacovigilance spontaneous reporting in France
    De Germay, S.
    Singier, A.
    Salvo, F.
    Pariente, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 18 - 19
  • [33] Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France
    de Germay, Sibylle
    Singier, Allison
    Salvo, Francesco
    Pariente, Antoine
    French Pharmacovigilance Network
    DRUG SAFETY, 2023, 46 (12) : 1381 - 1389
  • [34] Pesticide residues in tomato and tomato products marketed in Majmaah province, KSA, and their impact on human health
    Zeinab A. Abd-Elhaleem
    Environmental Science and Pollution Research, 2020, 27 : 8526 - 8534
  • [35] A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs
    Sarpatwari, Ameet
    Mitra-Majumdar, Mayookha
    Bykov, Katsiaryna
    Avorn, Jerry
    Woloshin, Steven
    Toyserkani, Gita A.
    LaCivita, Cynthia
    Manzo, Claudia
    Zhou, Esther H.
    Pinnow, Ellen
    Dal Pan, Gerald J.
    Gagne, Joshua J.
    Huybrechts, Krista F.
    Feldman, William B.
    Chin, Kristyn
    Kesselheim, Aaron S.
    DRUG SAFETY, 2021, 44 (07) : 743 - 751
  • [36] Pesticide residues in tomato and tomato products marketed in Majmaah province, KSA, and their impact on human health
    Abd-Elhaleem, Zeinab A.
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2020, 27 (08) : 8526 - 8534
  • [37] Development of a federally mandated risk evaluation and mitigation strategy (REMS) for transmucosal immediate-release fentanyl products
    Pergolizzi, J.
    Gharibo, C.
    Gudin, J.
    Nalamachu, S.
    JOURNAL OF PAIN, 2013, 14 (04) : S36 - S36
  • [38] Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products
    Pergolizzi, Joseph V.
    Gharibo, Christopher G.
    Gudin, Jeffrey A.
    Nalamachu, Srinivas R.
    PAIN PRACTICE, 2013, 13 (04) : 259 - 263
  • [39] Clinical evaluation of marketed orthodontic products: are researchers behind the times? A meta-epidemiological study
    Jadbinder Seehra
    Nikolaos Pandis
    Padhraig S. Fleming
    Progress in Orthodontics, 18
  • [40] Comparative Studies of Hyaluronan in Marketed Ophthalmic Products
    Liu, X. Michael
    Harmon, Patricia S.
    Maziarz, E. Peter
    Rah, Marjorie J.
    Merchea, Mohinder M.
    OPTOMETRY AND VISION SCIENCE, 2014, 91 (01) : 32 - 38
12345